Regeneron Pharmaceuticals
NY · 23 filings, 2025
What the money shows
Regeneron Pharmaceuticals reported $2.2M in federal lobbying for 2025 across 23 filings. The filings name 6 lobbying firms, led by Washington TAX & Public Policy and Checkmate Government Relations. The matched PAC file shows $20,000 to 0 lawmakers. The filing text lists 6 issue areas.
Sources: Senate LDA · FEC
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Taxation/Internal Revenue Code · Medicare/Medicaid · Copyright/Patent/Trademark · Trade (domestic/foreign) · Budget/Appropriations
2Through these firms · 6
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5224A bill to improve training for airport drivers in the movement area at commercial service airports through…